Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

The Trump Administration released America’s AI Action Plan (the “Plan”) on July 23, 2025, a comprehensive strategy to attempt to “win” the race to achieve global dominance in artificial intelligence ( ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

On July 24, 2025, the White House released the “White House AI Action Plan,” which includes over 90 policy actions focused on accelerating innovation, building AI infrastructure, and increasing ...

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...

A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...

The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...